Purified human papillomavirus type 33 (HPV-33) peptides as an im

Details Purified human papillomavirus type 33 (HPV-33) peptides as an im Purified human papillomavirus type 33 (HPV-33) peptides as an im

1997-07-15

1999-03-02

Mosher, Mary E.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Amino acid sequence disclosed in whole or in part; or...

536 2372, 536 241, 536 2432, 530324, 5303879, 435 5, 435 69, 4351723, A61K 3912, C07H 2104

Patent

active

058767231

ABSTRACT:
The invention concerns DNA fragments derived from the genomic DNA of HPV-33. These fragments are selected from the group of fragments extending between the nucleotide extremities defined hereafter in relation to the nucleotide-numbering in FIGS. 1a and 1b respectively

REFERENCES:
patent: 4358535 (1982-11-01), Falkow et al.
patent: 4419446 (1983-12-01), Howley et al.
patent: 4551270 (1985-11-01), Danos et al.
patent: 4748109 (1988-05-01), Baird
patent: 4849322 (1989-07-01), Lorincz
patent: 4849331 (1989-07-01), Lorincz
patent: 4849334 (1989-07-01), Lorincz
patent: 4983728 (1991-01-01), Herzog et al.
patent: 5057411 (1991-10-01), Lancaster et al.
patent: 5411857 (1995-05-01), Beaudenon et al.
patent: 5554538 (1996-09-01), Cole et al.
Barrasso, R., et al., "Lesions Genitales Masculines a Papillomavirus. Interet de la Colposcopie," Ann. Dermatol. Venereol. 113:787-795 (France 1986).
Beaudenon S., et al., "A novel type of human papillomavirus associated with genital neoplasias," Nature 321:246-249 (1986).
Coggin, Jr., J.R., et al., Meeting Report, Workshop on Papillomavirus and Cancer, Cancer Res.39:545-546 (1979).
Cole, S.T., et al., "Nucleotide Sequence and Comparative Analysis of the Human Papillomavirus Type 18 Genome: Phylogeny of Papillomaviruses and Repeated Structure of the E6 and E7 Gene Products," J. Mol. Biol. 193(4):599-608 (1987).
Cole, S.T., et al., "Genome Organizationand Nucleotide Sequence of Human Papillomavirus Type 33, Which is Associated with Cervical Cancer," J. Virol. 58(3):991-995 (1986).
Durst, M., et al., "A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions," Proc. Natl. Acad. Sci. USA 80:3812-3815 (1983).
Gissmann, L., et al., "Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers," Proc. Nalt. Acad. Sci. USA 80:560-563 (1983).
Kawashima, M., et al. "Characterization of a New Type of Human Papillomavirus Found in a Lesion of Bowen's Disease of the Skin," J. Virol. 57(2):688-692 (Feb. 1986).
Kremsdorf, D., et al., "Molecular Cloning and Characterization of the Genomes of Nine Newly Recognized Human Papillomavirus Types Associated with Epidermodysplasia Verruciformis," J. Virol. 52(3):1013-18 (Dec. 1984).
Kremsdorf, D., et al., "Biochemical Characterization of Two Types of Human Papillomaviruses Associated with Epidermodysplasia Verruciformis," J. Virol. 43(2):436-447 (1982).
Kremsdorf, D., et al., "Human Papillomavirus Associated with Epidermodysplasia Verruciformis. II. Molecular Cloning and Biochemical Characterization of Human Papillomavirus 3a, 8, 10, and 12 Genomes," J. Virol. 48(2):340-351 (1983).
Parent, B., et al., "Les dysplasies du col uterin," J. Gynecol. Obstet. Biol. Reprod. 15:941-947 (1986).
Pouwels, P.H., et al., Cloning Vectors, A Laboratory Manual, VIII:1-3, 5-7 (Elsevier, Amsterdam 1985).
Schwarz, E., et al., "DNA sequence and genome organization of genital human papillomavirus type 6b," EMBO J. 2(12):2341-2348 (1983).
Seedorf, K., et al., "Human Papillomavirus Type 16 DNA Sequence," Virol. 145:181-85 (1985).
Seedorf, K., et al., "Human Papillomavirus Type 16 DNA:Expression of Open Reading Frames in E. coli," UCLA Symp. Mol. Cell. Biol., New Ser. vol. 32: Papillomaviruses: Molecular and Clinical Aspects:391-396 (Alan R. Liss, Inc. 1985).
Chen et al., "The primary structure and genetic organization of the bovine papillomavirus type 1 genome," Nature, 299:529-534 (1982).
Danos et al., EMBO, 1(2):231-236 (1982).
Howley, "The Human Papillomaviruses," Arch. Pathol. Lab. Med., 106:429-432 (1982).
International Search Report for PCT International Patent Application No. PCT/EP 87/00158, mailed Jul. 27, 1987.
Katina et al., EMBO, 1(2):231-236 (1982).
Lancaster et al., "Human Papillomavirus . . . Uterine Cervix," Chem. Abst., 99(3):218, abst. 188882k, issued Dec. 5, 1983.
Orth et al., "Papillomavirus . . . infections," Chem. Abst., 106(25):348, abst. 210547s, issued Jun. 22, 1987.
Pfister, Rev. Biochem. Pharm., 99:111-181 (1983).
Rando et al., J. Virol., 57:353-356 (1986).
Riov et al., C.R. Acad. Sci., Ser III 14:575-580 (1984).
Suggs et al., Proc. Nat'l. Acad. Sci., 78:6613-6617 (1981).

Affiliated with

Also associated with

Rating

Purified human papillomavirus type 33 (HPV-33) peptides as an im does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Purified human papillomavirus type 33 (HPV-33) peptides as an im, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Purified human papillomavirus type 33 (HPV-33) peptides as an im will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-419734